Academic Bibliography

Show Sort by

Your filters: cql: parent exact "LANCET ONCOLOGY"

Mark
- journalArticle
- A1
Effect of early palliative care : complex intervention and complex results : authors' reply

Gaëlle Vanbutsele (UGent), Koen Pardon (UGent), Simon Van Belle (UGent), Veerle Surmont (UGent), Martine De Laat, Roos Colman (UGent), Kim Eecloo (UGent), Veronique Cocquyt (UGent), Karen Geboes (UGent) and Luc Deliens (UGent)

(2018) LANCET ONCOLOGY. 19(5). p.e222-e222
Mark
- journalArticle
- A1
A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma : a retrospective training and validation analysis in three international cohorts

Sarah Huet, Bruno Tesson, Jean-Philippe Jais, Andrew L Feldman, Laura Magnano, Emilie Thomas, Alexandra Traverse-Glehen, Benoit Albaud, Marjorie Carrere, Luc Xerri, et al.

(2018) LANCET ONCOLOGY. 19(4). p.549-561
Mark
- journalArticle
- A1
Effect of early and systematic integration of palliative care in patients with advanced cancer : a randomised controlled trial

Gaëlle Vanbutsele (UGent), Koen Pardon (UGent), Simon Van Belle (UGent), Veerle Surmont (UGent), Martine De Laat, Roos Colman (UGent), Kim Eecloo (UGent), Veronique Cocquyt (UGent), Karen Geboes (UGent) and Luc Deliens (UGent)

(2018) LANCET ONCOLOGY. 19(3). p.394-404
Mark
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global) : a combined analysis of three multicentre, randomised, phase 3 trials

Harpreet S Wasan, Peter Gibbs, Navesh K Sharma, Julien Taieb, Volker Heinemann, Jens Ricke, Marc Peeters, Michael Findlay, Andrew Weaver, Jamie Mills, et al.

(2017) LANCET ONCOLOGY. 18(9). p.1159-1171
Mark
- journalArticle
- A1
Definition and recommendations for advance care planning : an international consensus supported by the European Association for Palliative Care

Judith AC Rietjens, Rebecca L Sudore, Michael Connolly, Johannes J van Delden, Margaret A Drickamer, Mirjam Droger, Agnes van der Heide, Daren K Heyland, Dirk Houttekier, Daisy JA Janssen, et al.

(2017) LANCET ONCOLOGY. 18(9). p.e543-e551
Mark
- journalArticle
- A1
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN) : an international, randomised, multi-arm, open-label, phase 3 trial

Ruth Ladenstein, Ulrike Pötschger, Andrew D. J. Pearson, Penelope Brock, Roberto Luksch, Victoria Castel, Isaac Yaniv, Vassilios Papadakis, Genevieve Laureys (UGent), Josef Malis, et al.

(2017) LANCET ONCOLOGY. 18(4). p.500-514
Mark
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT) : an open-label, phase 3, randomised, superiority trial

Corinne Faivre-Finn, Michael Snee, Linda Ashcroft, Wiebke Appel, Fabrice Barlesi, Adityanarayan Bhatnagar, Andrea Bezjak, Felipe Cardenal, Pierre Fournel, Susan Harden, et al.

(2017) LANCET ONCOLOGY. 18(8). p.1116-1125
Mark
- journalArticle
- A1
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

A Chanan-Khan, P Cramer, F Demirkan, G Fraser, RS Silva, S Grosicki, A Pristupa, A Janssens, J Mayer, NL Bartlett, et al.

(2016) LANCET ONCOLOGY. 17(2). p.200-211
Mark
- journalArticle
- A1
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR) : a randomised, phase 3, open-label, multicentre study

Meletios A Dimopoulos, Philippe Moreau, Antonio Palumbo, Douglas Joshua, Ludek Pour, Roman Hájek, Thierry Facon, Heinz Ludwig, Albert Oriol, Hartmut Goldschmidt, et al.

(2016) LANCET ONCOLOGY. 17(1). p.27-38
Mark
- journalArticle
- A1
Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience

Tadashi Kamada, Hirohiko Tsujii, Eleanor A Blakely, Jürgen Debus, Wilfried De Neve (UGent), Marco Durante, Oliver Jäkel, Ramona Mayer, Roberto Orecchia, Richard Pötter, et al.

(2015) LANCET ONCOLOGY. 16(2). p.e93-e100

Academic Bibliography

Biblio has been updated

Effect of early palliative care : complex intervention and complex results : authors' reply

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma : a retrospective training and validation analysis in three international cohorts

Effect of early and systematic integration of palliative care in patients with advanced cancer : a randomised controlled trial

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global) : a combined analysis of three multicentre, randomised, phase 3 trials

Definition and recommendations for advance care planning : an international consensus supported by the European Association for Palliative Care

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN) : an international, randomised, multi-arm, open-label, phase 3 trial

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT) : an open-label, phase 3, randomised, superiority trial

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR) : a randomised, phase 3, open-label, multicentre study

Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience

Contents

Support

Contact